# begin document GENTLE_medical_hiv
0	Description	(abstract-1)
1	:	(2)
2	Human	(abstract-3(animal-4-HIV
3	immunodeficiency	_
4	virus	animal-4-HIV)
5	disease	_
6	with	_
7	stable	_
8	control	_
9	on	_
10	Atripla	(substance-5-Efavirenz/emtricitabine/tenofovir)abstract-3)
11	.	(6)
12	Resolving	(7)
13	left	(object-8
14	gluteal	_
15	abscess	object-8)
16	,	(9)
17	completing	(10)
18	Flagyl	(substance-11-Metronidazole)
19	.	(12)
20	Diabetes	(abstract-13-Diabetes
21	mellitus	abstract-13-Diabetes)
22	,	(14)
23	currently	(15)
24	on	(16)
25	oral	(abstract-17
26	therapy	abstract-17)
27	.	(18)
28	Hypertension	(abstract-19)
29	,	(20)
30	depression	(abstract-21)
31	,	(22)
32	and	(23)
33	chronic	(abstract-24
34	musculoskeletal	_
35	pain	_
36	of	_
37	unclear	(abstract-25
38	etiology	abstract-24)abstract-25)
39	.	(26)
40	HISTORY	(abstract-27
41	OF	_
42	PRESENT	(abstract-3
43	ILLNESS	abstract-27)abstract-3)
44	:	(28)
45	The	(person-29
46	patient	person-29)
47	is	(30)
48	a	(person-29
49	41	_
50	-	_
51	year	_
52	-	_
53	old	_
54	white	_
55	male	_
56	with	_
57	a	(abstract-27
58	history	_
59	of	_
60	HIV	(abstract-3(animal-4-HIV)
61	disease	person-29)abstract-27)abstract-3)
62	.	(31)
63	His	(abstract-32(person-29)
64	last	_
65	CD4	(animal-33-CD4)
66	count	abstract-32)
67	was	(34)
68	425	(abstract-32)
69	,	(35)
70	viral	(abstract-36
71	load	abstract-36)
72	was	(37)
73	less	(38)
74	than	(39)
75	50	(abstract-40)
76	in	(41)
77	08	(time-42
78	/	_
79	07	time-42)
80	.	(43)
81	He	(person-29)
82	was	(44)
83	recently	(45)
84	hospitalized	(46)
85	for	(47)
86	left	(object-8
87	gluteal	_
88	abscess	_
89	,	_
90	for	_
91	which	_
92	he	(person-29)
93	underwent	_
94	I	(event-48
95	&	_
96	D	object-8)event-48)
97	and	(49)
98	he	(person-29)
99	has	(50)
100	newly	(51)
101	diagnosed	(52)
102	diabetes	(abstract-13-Diabetes
103	mellitus	abstract-13-Diabetes)
104	.	(53)
105	He	(person-29)
106	also	(54)
107	has	(55)
108	a	(abstract-56
109	history	_
110	of	_
111	hypertension	(abstract-19)
112	and	_
113	hypertriglyceridemia	(abstract-57)abstract-56)
114	.	(58)
115	He	(person-29)
116	had	(59)
117	been	(60)
118	having	(61)
119	increased	(62)
120	urination	(event-63)
121	and	(64)
122	thirst	(abstract-65)
123	.	(66)
124	He	(person-29)
125	was	(67)
126	seen	(68)
127	in	(69)
128	the	(place-70
129	hospital	place-70)
130	by	(71)
131	the	(person-72
132	endocrinology	_
133	staff	person-72)
134	and	(73)
135	treated	(74)
136	with	(75)
137	insulin	(substance-76)
138	while	(77)
139	hospitalized	(78)
140	and	(79)
141	getting	(80)
142	treatment	(abstract-81
143	for	_
144	his	(person-29)
145	perirectal	(object-8
146	abscess	abstract-81)object-8)
147	.	(82)
148	The	(organization-83
149	endocrine	_
150	team	organization-83)
151	apparently	(84)
152	felt	(85)
153	that	(86)
154	insulin	(substance-76)
155	might	(87)
156	be	(88)
157	best	(89)
158	for	(90)
159	this	(person-29
160	patient	person-29)
161	,	(91)
162	but	(92)
163	because	(93)
164	of	(94)
165	financial	(abstract-95
166	issues	abstract-95)
167	,	(96)
168	elected	(97)
169	to	(98)
170	place	(99)
171	him	(person-29)
172	on	(100)
173	Glucophage	(substance-101(substance-102-Metformin)
174	and	_
175	glyburide	(substance-103-Glibenclamide)substance-101)
176	.	(104)
177	The	(person-29
178	patient	person-29)
179	reports	(105)
180	that	(106)
181	he	(person-29)
182	has	(107)
183	been	(108)
184	taking	(109)
185	the	(substance-101
186	medication	substance-101)
187	.	(110)
188	He	(person-29)
189	is	(111)
190	in	(112)
191	general	(113)
192	feeling	(114)
193	better	(115)
194	.	(116)
195	He	(person-29)
196	says	(117)
197	that	(118)
198	his	(object-8(person-29)
199	gluteal	_
200	abscess	object-8)
201	is	(119)
202	improving	(120)
203	and	(121)
204	he	(person-29)
205	will	(122)
206	be	(123)
207	following	(124)
208	up	(125)
209	with	(126)
210	Surgery	(event-127)
211	today	(time-128)
212	.	(129)
213	CURRENT	(abstract-130
214	MEDICATIONS	abstract-130)
215	:	(131)
216	1.	(132)
217	Gabapentin	(substance-133-Gabapentin)
218	600	(substance-134
219	mg	substance-134)
220	at	(135)
221	night	(time-136)
222	.	(137)
223	2.	(138)
224	Metformin	(substance-139-Metformin)
225	1000	(substance-140
226	mg	substance-140)
227	twice	(141)
228	a	(time-142
229	day	time-142)
230	.	(143)
231	3.	(144)
232	Glipizide	(substance-145-Glipizide)
233	5	(substance-146
234	mg	substance-146)
235	a	(time-142
236	day	time-142)
237	.	(147)
238	4.	(148)
239	Flagyl	(substance-11-Metronidazole)
240	500	(substance-149
241	mg	substance-149)
242	four	(150)
243	times	(151)
244	a	(time-142
245	day	time-142)
246	.	(152)
247	5.	(153)
248	Flexeril	(substance-154-Cyclobenzaprine)
249	10	(substance-155
250	mg	substance-155)
251	twice	(156)
252	a	(time-142
253	day	time-142)
254	.	(157)
255	6.	(158)
256	Paroxetine	(substance-159-Paroxetine)
257	20	(substance-160
258	mg	substance-160)
259	a	(time-142
260	day	time-142)
261	.	(161)
262	7.	(162)
263	Atripla	(substance-5-Efavirenz/emtricitabine/tenofovir)
264	one	(object-163)
265	at	(164)
266	night	(time-136)
267	.	(165)
268	8.	(166)
269	Clonazepam	(substance-167-Clonazepam)
270	1	(substance-168
271	mg	substance-168)
272	twice	(169)
273	a	(time-142
274	day	time-142)
275	.	(170)
276	9.	(171)
277	Blood	(abstract-172(abstract-173(substance-174)
278	pressure	abstract-173)
279	medicine	abstract-172)
280	,	(175)
281	name	(abstract-176)
282	unknown	(177)
283	.	(178)
284	REVIEW	(abstract-179
285	OF	_
286	SYSTEMS	(abstract-180)abstract-179)
287	:	(181)
288	He	(person-29)
289	otherwise	(182)
290	has	(183)
291	a	(abstract-184
292	negative	_
293	review	_
294	of	_
295	systems	(abstract-180)abstract-184)
296	.	(185)
297	PHYSICAL	(abstract-186
298	EXAMINATION	abstract-186)
299	:	(187)
300	VITAL	(abstract-188
301	SIGNS	abstract-188)
302	:	(189)
303	Temperature	(abstract-190)
304	36.6	(abstract-190)
305	,	(191)
306	blood	(abstract-173(substance-174)
307	pressure	abstract-173)
308	145	(abstract-173
309	/	_
310	90	abstract-173)
311	,	(192)
312	pulse	(abstract-193)
313	123	(abstract-193)
314	,	(194)
315	respirations	(abstract-195)
316	20	(abstract-195)
317	,	(196)
318	and	(197)
319	weight	(abstract-198)
320	is	(199)
321	89.9	(abstract-198
322	kg	abstract-198)
323	(	(200)
324	198	(abstract-198
325	pounds	abstract-198)
326	.	(201)
327	)	(202)
328	HEENT	(abstract-203)
329	:	(204)
330	Unremarkable	(205)
331	except	(206)
332	for	(207)
333	some	(object-208
334	submandibular	_
335	lymph	_
336	nodes	object-208)
337	.	(209)
338	His	(object-210(person-29)
339	fundi	object-210)
340	are	(211)
341	benign	(212)
342	.	(213)
343	NECK	(object-214)
344	:	(215)
345	Supple	(216)
346	.	(217)
347	LUNGS	(object-218)
348	:	(219)
349	Clear	(220)
350	to	(221)
351	auscultation	(abstract-222)
352	and	(223)
353	percussion	(abstract-224)
354	.	(225)
355	CARDIAC	(226)
356	:	(227)
357	Reveals	(228)
358	regular	(abstract-229
359	rate	_
360	and	_
361	rhythm	(abstract-230
362	without	_
363	murmur	(event-231)
364	,	_
365	rub	(event-232)
366	or	_
367	gallop	(event-233)abstract-229)abstract-230)
368	.	(234)
369	ABDOMEN	(object-235)
370	:	(236)
371	Soft	(237)
372	and	(238)
373	nontender	(239)
374	without	(240)
375	organomegaly	(event-241)
376	or	(242)
377	mass	(object-243)
378	.	(244)
379	EXTREMITIES	(object-245)
380	:	(246)
381	Show	(247)
382	no	(248)
383	cyanosis	(event-249)
384	,	(250)
385	clubbing	(event-251)
386	or	(252)
387	edema	(event-253)
388	.	(254)
389	GU	(255)
390	:	(256)
391	Examination	(event-257
392	of	_
393	the	(object-258
394	perineum	event-257)object-258)
395	revealed	(259)
396	an	(object-8
397	open	_
398	left	_
399	gluteal	_
400	wound	_
401	that	_
402	appears	_
403	clear	_
404	with	_
405	no	(object-260
406	secretions	object-8)object-260)
407	.	(261)
408	IMPRESSION	(abstract-262)
409	:	(263)
410	1.	(264)
411	Human	(abstract-3(animal-4-HIV
412	immunodeficiency	_
413	virus	animal-4-HIV)
414	disease	_
415	with	_
416	stable	_
417	control	_
418	on	_
419	Atripla	(substance-5-Efavirenz/emtricitabine/tenofovir)abstract-3)
420	.	(265)
421	2.	(266)
422	Resolving	(267)
423	left	(object-8
424	gluteal	_
425	abscess	object-8)
426	,	(268)
427	completing	(269)
428	Flagyl	(substance-11-Metronidazole)
429	.	(270)
430	3.	(271)
431	Diabetes	(abstract-13-Diabetes
432	mellitus	abstract-13-Diabetes)
433	,	(272)
434	currently	(273)
435	on	(274)
436	oral	(abstract-17
437	therapy	abstract-17)
438	.	(275)
439	4.	(276)
440	Hypertension	(abstract-19)
441	.	(277)
442	5.	(278)
443	Depression	(abstract-21)
444	.	(279)
445	6.	(280)
446	Chronic	(abstract-24
447	musculoskeletal	_
448	pain	_
449	of	_
450	unclear	(abstract-25
451	etiology	abstract-24)abstract-25)
452	.	(281)
453	PLAN	(abstract-282)
454	:	(283)
455	The	(person-29
456	patient	person-29)
457	will	(284)
458	continue	(285)
459	his	(abstract-130(person-29)
460	current	_
461	medications	abstract-130)
462	.	(286)
463	He	(person-29)
464	will	(287)
465	have	(288)
466	laboratory	(abstract-289
467	studies	abstract-289)
468	done	(290)
469	in	(291)
470	3	(time-292
471	to	_
472	4	_
473	weeks	time-292)
474	,	(293)
475	and	(294)
476	we	(person-295)
477	will	(296)
478	see	(297)
479	him	(person-29)
480	a	(time-292
481	few	_
482	weeks	_
483	thereafter	time-292)
484	.	(298)
485	He	(person-29)
486	has	(299)
487	been	(300)
488	encouraged	(301)
489	to	(302)
490	keep	(303)
491	his	(event-304(person-29)
492	appointment	_
493	with	_
494	his	(person-305(person-29)
495	psychologist	event-304)person-305)
496	.	(306)
# end document

